Evaxion Biotech (NASDAQ:EVAX) is gearing up to announce its quarterly earnings on Thursday, 2026-03-05. Here’s a quick overview of what investors should know before the release.

Analysts are estimating that Evaxion Biotech will report an earnings per share (EPS) of $-0.19.

Investors in Evaxion Biotech are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Past Earnings Performance

The company’s EPS …

Full story available on Benzinga.com